Drug Metabolism Reviews

Papers
(The H4-Index of Drug Metabolism Reviews is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cytochrome P450 expression and regulation in the brain58
Pharmacology of apocynin: a natural acetophenone42
Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial36
Drug metabolic stability in early drug discovery to develop potential lead compounds32
Toxicity mechanisms of nanoparticles in the male reproductive system26
Pharmacogenomics in the era of next generation sequencing – from byte to bedside22
The role of UDP-glycosyltransferases in xenobioticresistance21
Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases20
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs19
Recent developments inin vitroandin vivomodels for improved translation of preclinical pharmacokinetics and pharmacodynamics data19
In quest of a new therapeutic approach in COVID-19: the endocannabinoid system18
Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.18
Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism17
The relationship between UGT1A1 gene & various diseases and prevention strategies15
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy15
0.19775104522705